4 天前 - … in various cellular processes and is … disease. Aberrant expression of specific miRNAs
or lncRNAs has been associated with conditions such as cancer, cardiovascular diseases, …

5 天前 - … linking these dysregulated interactions to cardiovascular diseases and potentially
to … to active participants in cellular metabolism, signaling, and disease pathogenesis. …

6 天前 - … miRNAs, involved in cellular and metabolic pathways’ … and secondary prevention
in cardiovascular diseases (CVD)… , bone, and joint diseases (chronic fatigue syndrome and …

7 天前 - … a long history of use in treating cardiovascular diseases. Natural compounds derived
from … This finding expands our understanding of the cellular and molecular mechanisms …

7 天前 - … including cardiovascular diseases. Understanding the influence of miRNAs and
their target … This pathway plays a crucial role in various key cellular processes, including cell …

8 天前 - … in cardiovascular disease, including cardiac hypertrophy. Two categories defined
as pro-hypertrophic and anti-hypertrophic microRNAs are involved in cardiac hypertrophy. …

10 天前 - … Cellular senescence, an attractive target for age-related … the burden of human
cardiovascular disease, so we must … of chronologic and premature cardiac aging. This phase will …

11 天前 - … Pulmonary hypertension (PAH) is a cardiopulmonary disease in which pulmonary
artery … , and regulating Otud6b expression may be an effective target for the treatment of PAH. …

12 天前 - … processes but also interacts with various cellular components, leading to endothelial
… In the context of comprehensive control of other cardiovascular disease (CVD) risk …

12 天前 - … regulation by miRNA-15b (miR-15b) were evaluated by animal MI and cellular
hypoxic … in various cardiovascular diseases and have become potential targets for therapeutic …